STOCK TITAN

Agilent Technologies (A) Stock News

A NYSE

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Agilent Technologies Inc. reports developments across analytical and clinical laboratory technologies, including instruments, software, services and scientific expertise used by life science, diagnostics, applied, biopharmaceutical, chemical, advanced materials, clinical lab, environmental, food, forensics, academic and government customers. Company updates commonly address financial results, product launches, laboratory workflows and changes in senior legal, governance and compliance leadership.

Recent Agilent news has highlighted the BioTek Cytation 9 cell imaging multimode reader for cell-based research and high-content screening, cancer research and diagnostics workflows, and FDA-approved companion diagnostic indications for PD-L1 IHC 22C3 pharmDx, including use in identifying certain esophageal or gastroesophageal junction carcinoma patients who may be eligible for KEYTRUDA.

Rhea-AI Summary

Agilent Technologies (NYSE: A) has launched three new models in its Dako Omnis instrument family to address diverse pathology laboratory needs. The new lineup includes the Dako Omnis 110 for low-medium volume labs (110 IHC slides/day), Dako Omnis 165 for medium-high volume labs (165 IHC slides/day), and Dako Omnis 165 Duo for simultaneous IHC and ISH processing.

The new instruments feature continuous case-based processing, shared reagents, and an integrated direct connection for de-ionized water and non-hazardous waste to improve workflow efficiency. The products will be initially available in the U.S., Europe, and Australia, with debuts planned at the European Congress of Pathology and National Society for Histotechnology events.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Summary

Crawford & Company (NYSE: CRD-A and CRD-B) announced an increase in its quarterly dividend. The Board of Directors approved a quarterly dividend of $0.075 per share for both Class A and Class B Common Stock, representing a $0.005 increase from the previous quarter.

The dividend will be paid on August 29, 2025, to shareholders of record as of August 15, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.14%
Tags
dividends
-
Rhea-AI Summary

Agilent Technologies (NYSE: A) has announced it will release its third quarter fiscal 2025 financial results on Wednesday, August 27, 2025, after market close. The company will host a conference call at 1:30 p.m. PDT the same day to discuss the results. Investors can access the listen-only webcast through the Events section of Agilent's investor relations website. A replay of the call will remain available on the website for 90 days.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.04%
Tags
News
Rhea-AI Summary

Agilent Technologies (NYSE: A) announced that Senior Vice President and CFO Bob McMahon will step down effective July 31, as he relocates to the East Coast for family reasons. Rodney Gonsalves, the company's current corporate controller and principal accounting officer, will serve as interim CFO while a global search for McMahon's successor is conducted.

The company also confirmed that its Q3 FY2025 financial results, to be released on August 27, are expected to be within the previously provided guidance range. Agilent maintains confidence in its long-term plans.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.95%
Tags
none
-
Rhea-AI Summary
Agilent Technologies announced plans to showcase new laboratory equipment at HPLC 2025 in Bruges, Belgium. The company will introduce their new Hybrid Multisampler and LC Single Quadrupole Mass Spectrometers. The InfinityLab Pro iQ Series features enhanced sensitivity for analyzing oligonucleotides, therapeutic peptides, and proteins, with real-time status feedback and mass-based fraction collection capabilities. The eco-friendly system has earned MyGreenLab ACT EcoLabel 2.0 certification. The 1290 Infinity III Hybrid Multisampler offers both traditional flow-through and Feed Injection Mode, reducing sample preparation time and ensuring better peak shapes. Early adopters like Novopor Advanced Science report significant workflow improvements, praising the system's robustness, reproducibility, and user-friendly interface. Agilent will also preview a new fluorescence detector and showcase enhanced serviceable flow cells and expanded Bio Core offerings.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary
Crawford & Company (NYSE: CRD-A and CRD-B) has appointed Amy Shore as an independent director effective June 6, 2025, expanding their board to ten directors, including three women. Shore brings over 30 years of leadership experience in financial services, most recently serving as chief transformation officer at Nationwide Insurance. In her previous role as chief customer officer, she managed customer strategy for a $60B enterprise serving 14 million customers. Shore holds a bachelor's degree from Bowling Green State University, where she currently serves as board chair, and has completed executive programs at Northwestern's Kellogg School and UC Berkeley. A 2023 finalist for 50/50 Women on Boards' "50 Women to Watch for Boards," Shore's expertise in business transformation, customer experience, and operational excellence is expected to contribute to Crawford's strategic growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
management
Rhea-AI Summary
TORM plc has announced a capital increase through the issuance of 11,236 A-shares, with a nominal value of USD 112.36, as part of its incentive program involving Restricted Share Units. The new shares were subscribed for in cash at DKK 0.08 per A-share and will carry the same rights as existing ordinary shares, including dividend rights from the issuance date. Following this capital increase, TORM's total share capital stands at USD 979,524.31, consisting of 97,952,429 A-shares, one B-share, and one C-share, all with a nominal value of USD 0.01 each. The A-shares carry a total of 97,952,429 votes, while the B and C shares have specific voting rights.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.93%
Tags
none
-
Rhea-AI Summary
TORM (TRMD) has acquired the remaining 25% stake in ME Production (MEP), a Danish industrial engineering company specializing in green maritime equipment, gaining full ownership after initially acquiring 75% in 2022. The companies have collaborated since 2018, with MEP installing over 70 exhaust gas cleaning systems on TORM vessels. MEP will maintain its independence and headquarters in Frederikshavn, Denmark. Through their partnership, TORM achieved a 40% reduction in CO₂ intensity compared to 2008, surpassing IMO's 2030 target by six years. MEP's key innovations include heat pump systems for reducing energy use in ships and industrial facilities. As sole owner, TORM will provide enhanced strategic support and investment to accelerate MEP's growth as an innovation center for clean maritime technologies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.54%
Tags
-
Rhea-AI Summary
Agilent Technologies (NYSE: A) reported strong Q2 FY2025 financial results with revenue of $1.67 billion, representing 6.0% reported growth and 5.3% core growth year-over-year. The company's GAAP net income was $215 million ($0.75 EPS), down 29% from Q2 2024, while non-GAAP net income reached $373 million ($1.31 EPS), up 7%. By segment, Life Sciences and Diagnostics Markets Group revenue grew 8% to $654 million, Agilent CrossLab Group increased 7% to $713 million, while Applied Markets Group declined 1% to $301 million. For FY2025, Agilent projects revenue between $6.73-6.81 billion (3.4-4.6% growth) and non-GAAP EPS of $5.54-5.61. Q3 outlook expects revenue of $1.645-1.675 billion with non-GAAP EPS of $1.35-1.37.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.16%
Tags
Rhea-AI Summary

Agilent Technologies (NYSE: A) has appointed August Specht, Ph.D. as its new Chief Technology Officer, effective June 9, 2025. Specht joins Agilent from Thermo Fisher Scientific, where he served as vice president of Global R&D for the Chromatography and Mass Spectrometry Division. With over 25 years of experience in analytical instruments, software, and consumables development, Specht brings extensive expertise in R&D, product management, strategy, and business development from his roles at Thermo Fisher and Varian Instruments.

Specht holds a B.S. in Chemistry from Queen's University, a Ph.D. in Analytical Chemistry from the University of British Columbia, and an MBA from UC Berkeley. Agilent, a global leader in analytical and clinical laboratory technologies, reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.34%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $129.76 as of June 12, 2026.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 36.6B.